Literature DB >> 16528081

Atopic and non-atopic eczema.

Sara Brown1, Nick J Reynolds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16528081      PMCID： PMC1397720          DOI： 10.1136/bmj.332.7541.584

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  38 in total

1.  Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope.

Authors:  H Sugiura; H Ebise; T Tazawa; K Tanaka; Y Sugiura; M Uehara; K Kikuchi; T Kimura
Journal:  Br J Dermatol       Date:  2005-01       Impact factor: 9.302

2.  Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children.

Authors:  A W Lucky; A D Leach; P Laskarzewski; H Wenck
Journal:  Pediatr Dermatol       Date:  1997 Jul-Aug       Impact factor: 1.588

3.  Long-term follow-up of eczema patients treated with cyclosporine.

Authors:  H Granlund; P Erkko; S Reitamo
Journal:  Acta Derm Venereol       Date:  1998-01       Impact factor: 4.437

Review 4.  Guidelines for prescribing azathioprine in dermatology.

Authors:  A V Anstey; S Wakelin; N J Reynolds
Journal:  Br J Dermatol       Date:  2004-12       Impact factor: 9.302

Review 5.  The immunogenetics of asthma and eczema: a new focus on the epithelium.

Authors:  William Cookson
Journal:  Nat Rev Immunol       Date:  2004-12       Impact factor: 53.106

6.  Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

Authors:  Simon J Meggitt; Janine C Gray; Nick J Reynolds
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

7.  Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety.

Authors:  W W Epinette; C M Parker; E L Jones; M C Greist
Journal:  J Am Acad Dermatol       Date:  1987-12       Impact factor: 11.527

Review 8.  New insights into atopic dermatitis.

Authors:  Donald Y M Leung; Mark Boguniewicz; Michael D Howell; Ichiro Nomura; Qutayba A Hamid
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

Authors:  H C Williams; P G Burney; R J Hay; C B Archer; M J Shipley; J J Hunter; E A Bingham; A Y Finlay; A C Pembroke; R A Graham-Brown
Journal:  Br J Dermatol       Date:  1994-09       Impact factor: 9.302

10.  Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis.

Authors:  B B Tan; D Weald; I Strickland; P S Friedmann
Journal:  Lancet       Date:  1996-01-06       Impact factor: 79.321
View more
  18 in total

Review 1.  Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.

Authors:  Jocelyn M Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

2.  Educational programmes for young people with eczema.

Authors:  Hywel C Williams
Journal:  BMJ       Date:  2006-04-22

Review 3.  Eczema in pregnancy.

Authors:  Sophie Weatherhead; Stephen C Robson; Nick J Reynolds
Journal:  BMJ       Date:  2007-07-21

Review 4.  Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

Authors:  T C Theoharides; D Kempuraj; M Tagen; M Vasiadi; C L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

5.  Trends in the epidemiology and prescribing of medication for eczema in England.

Authors:  Colin R Simpson; John Newton; Julia Hippisley-Cox; Aziz Sheikh
Journal:  J R Soc Med       Date:  2009-03       Impact factor: 5.344

6.  Filaggrin null mutations and childhood atopic eczema: a population-based case-control study.

Authors:  Sara J Brown; Caroline L Relton; Haihui Liao; Yiwei Zhao; Aileen Sandilands; Ian J Wilson; John Burn; Nick J Reynolds; W H Irwin McLean; Heather J Cordell
Journal:  J Allergy Clin Immunol       Date:  2008-03-04       Impact factor: 10.793

7.  Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect.

Authors:  Sara J Brown; Karin Kroboth; Aileen Sandilands; Linda E Campbell; Elizabeth Pohler; Sanja Kezic; Heather J Cordell; W H Irwin McLean; Alan D Irvine
Journal:  J Invest Dermatol       Date:  2011-11-10       Impact factor: 8.551

8.  Genome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis.

Authors:  Katarina Tengvall; Marcin Kierczak; Kerstin Bergvall; Mia Olsson; Marcel Frankowiack; Fabiana H G Farias; Gerli Pielberg; Örjan Carlborg; Tosso Leeb; Göran Andersson; Lennart Hammarström; Åke Hedhammar; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2013-05-09       Impact factor: 5.917

9.  Refractory atopic dermatitis in childhood: improvement with methotrexate?

Authors:  Young Woon Park; Kkot Bora Yeom; Kyu Han Kim
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

10.  Antibiotics and allergic disorders in childhood.

Authors:  Sue Jordan; Mel Storey; Gareth Morgan
Journal:  Open Nurs J       Date:  2008-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.